PDF herunterladen
Synthesis 2009(16): 2766-2772  
DOI: 10.1055/s-0029-1216908
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis and Biological Evaluation of 6-Substituted Purinylcarbanucleosides with a Cyclopenta[b]thiophene Pseudosugar

Paula Abeijóna, José M. Blanco*a, Olga Caamañoa, Franco Fernándeza, Marcos D. Garcíab, Xerardo García-Meraa, José E. Rodríguez-Borgesc, Jan Balzarinid, Erik De Clercqd
a Departamento de Química Orgánica, Facultade de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
Fax: +34(981)594912; e-Mail: jm.blanco@usc.es ;
b Departmento de Química Fundamental, Facultade de Ciencias, Campus da Zapateira s/n, 15701 A Coruña, Spain
c CIQ, Departamento de Química, Facultade de Ciencias do Porto, Rua do Campo Alegre, 687-4169007 Porto, Portugal
d Rega Institute for Medical Research, Katholieke Universiteit Leuven, 3000 Leuven, Belgium
Weitere Informationen

Publikationsverlauf

Received 16 April 2009
Publikationsdatum:
14. Juli 2009 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

The first members of a new family of heterocarbobicyclic nucleoside analogues have been synthesized from the cis/trans mixture of (4-amino-5,6-dihydro-4H-cyclopenta[b]thiophen-6-yl)methanols (cis/trans -7). The separation of the cis and trans intermediates during the preparation of the 6-chloropurine derivatives allowed a separate preparation of the purine heterocarbanucleosides cis-10 and trans-11, from which cis-12-14 and trans-16-18 were obtained by replacement of the 6-chloro substituent with amino, hydroxy, and cyclopropylamino groups. Additionally, the 6-phenylpurinyl analogues cis-15 and trans- 19 were prepared from cis-10 and trans-11 using Suzuki-Miyaura methodology. In tests of antiviral and cytostatic activities, compound 11 showed cytostatic activity against Molt4/C8 human T lymphoblastic leukemia cells. Antiviral activity was shown by compounds 15 and 19 against Punta­ Toro virus and Coxackie virus B4 (compound 11).

Key words

heterobicyclic amino alcohol - cyclopenta[b]thiophene - Suzuki-Miyaura cross-coupling reaction - purinylcarbanucleoside - biological activity

    References

  • 1a Vermeire K. Schols D. Bell TW. Curr. Med. Chem.  2006,  13:  731 
    Google Scholar
  • 1b De Clercq E. J. Med. Chem.  2005,  48:  1297 
    Google Scholar
  • 1c De Clercq E. Front. Med. Chem.  2004,  1:  543 
    Google Scholar
  • 1d Lazzarin A. Clotet B. Cooper D. Reynes J. Arastéh D. Nelson M. Katlama C. Stellbrink H.-J. Delfraissy J.-F. Lange J. Huson L. DeMasi R. Wat C. Delehanty J. Drobnes C. Salgo M. N. Engl. J. Med.  2003,  348:  2186 
    Google Scholar
  • 2 Mansour TS. Storer R. Curr. Pharm. Des.  1997,  3:  227 
    Google Scholar
  • 3a Nucleoside Analogs in Cancer Therapy   Cheson BD. Keating MJ. Plunkett W. Marcel Dekker; New York: 1997. 
    Google Scholar
  • 3b De Clercq E. Clin. Microb. Rev.  1997,  10:  674 
    Google Scholar
  • 3c De Clercq E. Curr. Med. Chem.  2001,  8:  1543 
    Google Scholar
  • 3d Ena J. Pasquau F. Clin. Infect. Dis.  2003,  36:  1186 
    Google Scholar
  • 3e Louie M. Hogan C. Di Mascio M. Hurley A. Simon V. Rooney J. Ruiz N. Brun S. Sun E. Perelson AS. Ho DD. Markowitz M. J. Infect. Dis.  2003,  187:  896 
    Google Scholar
  • 4 Balzarini J. Kang G.-J. Dala M. Herdewijn P. De Clercq E. Broker S. Johns DG. Mol. Pharmacol.  1987,  32:  162 
    Google Scholar
  • 5 Lea AP. Faulds D. Drugs  1996,  51:  846 
    CrossrefGoogle Scholar
  • 6 Krayevsky AA. Watanabe KA. Modified Nucleosides as Anti-AIDS Drugs: Current Status and Perspectives   Bioinform; Moscow: 1993. 
    Google Scholar
  • 7 Thomas S. McDowall JE. Cheah V. Bye A. Segal MB. The Entry of Abacavir into the Guinea Pig Brain: Comparison with Other Reverse Transcriptase Inhibitors   Presented at the 12th World AIDS Conference, Geneva; Italy: 1998. 
    Google Scholar
  • For recent reviews of the biological properties of CNs, see:
  • 8a Cho JH. Bernard DL. Sidwell RW. Kern ER. Chu CK. J. Med. Chem.  2006,  49:  1140 
    Google Scholar
  • 8b Schneller SW. Curr. Top. Med. Chem.  2002,  2:  1087 
    Google Scholar
  • 8c Rodríguez JB. Comin MJ. Mini Rev. Med. Chem.  2003,  3:  95 
    Google Scholar
  • 8d Ichicawa E. Kato K. Curr. Med. Chem.  2001,  8:  385 
    Google Scholar
  • 8e Zhu X.-F. Nucleosides, Nucleotides Nucleic Acids  2000,  19:  651 
    Google Scholar
  • 8f Agrofoglio L. Challand SR. Acyclic, Carbocyclic and l -Nucleosides   Klewer Academic; Dordrecht: 1998. 
    Google Scholar
  • 9 Crimmins MT. King BW. J. Org. Chem.  1996,  61:  4192 
    CrossrefGoogle Scholar
  • 10a Foster RH. Faulds D. Drugs  1998,  55:  729 
    Google Scholar
  • 10b Daluge SM. Martín MT. Sickles BR. Livingston DA. Nucleosides, Nucleotides Nucleic Acids  2000,  19:  297 
    Google Scholar
  • 10c Mahony WB. Domin BA. Daluge SM. Zimmerman TP. Biochem. Pharmacol.  2004,  68:  1797 
    Google Scholar
  • 10d Opravil M. Hirschel B. Lazzarin A. Furrer H. Chave J.-P. Yerly S. Bisset LR. Fischer M. Vernazza P. Benasconi E. Battegay M. Ledergerber B. Günthard H. Howe C. Weber R. Perrin L. J. Infect. Dis.  2002,  185:  1251 
    Google Scholar
  • 11 Bisacchi GS. Chao ST. Bachard C. Daris JP. Innaimo S. Jacobs GA. Kocy O. Lapointe P. Martel A. Merchant Z. Slusarchyk WA. Sundeen JE. Young MG. Colonno R. Zahler R. Bioorg. Med. Chem. Lett.  1997,  7:  127 
    CrossrefGoogle Scholar
  • 12 Wyatt PG. Anslow AS. Coomber BA. Cousins RPC. Evans DN. Gilbert VS. Humber DC. Paternoster IL. Sollis SL. Tapolczay DJ. Weingarten GG. Nucleosides Nucleotides  1995,  14:  2039 
    Google Scholar
  • 13a Fernández F. García-Mera X. Morales M. Rodríguez-Borges JE. Synthesis  2001,  239 
    Google Scholar
  • 13b Fernández F. García-Mera X. Morales M. Vilariño L. Caamaño O. De Clercq E. Tetrahedron  2004,  60:  9245 
    Google Scholar
  • 13c Fernández F. García-Mera X. López C. Morales M. Rodríguez-Borges JE. Synthesis  2005,  3549 
    Google Scholar
  • 14a Fernández F. García-Mera X. Morales M. Rodríguez-Borges JE. De Clercq E. Synthesis  2002,  1084 
    Google Scholar
  • 14b Yao S.-W. Lopes VHC. Fernández F. García-Mera X. Morales M. Rodríguez-Borges JE. Cordeiro MNDS. Bioorg. Med. Chem.  2003,  11:  4999 
    Google Scholar
  • 15 Hocek M. Hol A. Votruba I. Dvoráková H. J. Med. Chem.  2000,  43:  1817 
    CrossrefGoogle Scholar
  • 16a García MD. Caamaño O. Fernández F. Abeijón P. Blanco JM. Synthesis  2006,  73 
    Google Scholar
  • 16b Caamaño O. Gómez G. Fernández F. García MD. García-Mera X. De Clercq E. Synthesis  2004,  2855 
    Google Scholar
  • 16c Hergueta AR. López C. García-Mera X. Fernández F. Tetrahedron  2004,  60:  10343 
    Google Scholar
  • 16d García MD. Caamaño O. Fernández F. Figueira MJ. Gómez G. Synthesis  2003,  2138 
    Google Scholar
  • 16e López C. Caamaño O. Hergueta AR. García MD. Fernández F. Tetrahedron Lett.  2002,  43:  5311 
    Google Scholar
  • 17 García MD. Caamaño O. Fernández F. López C. De Clercq E. Synthesis  2005,  925 
    Artikel in Thieme ConnectGoogle Scholar
  • 18 García MD. Caamaño O. Fernández F. García-Mera X. Pérez-Castro I. Synthesis  2006,  3967 
    Artikel in Thieme ConnectGoogle Scholar
  • 19a Blanco JM. Caamaño O. Fernández F. Rodríguez-Borges JE. Balzarini J. De Clercq E. Chem. Pharm. Bull.  2003,  51:  1060 
    Google Scholar
  • 19b Guan H.-P. Ksebati MB. Cheng YC. Drach JC. Kern ER. Zemlicka J. J. Org. Chem.  2000,  65:  1280 
    Google Scholar
  • 20 Abeijón P. Blanco JM. Fernández F. García MD. López C. Eur. J. Org. Chem.  2006,  759 
    CrossrefGoogle Scholar
  • 21 Yoon NM. Brown HC. J. Am. Chem. Soc.  1968,  90:  2927 
    CrossrefGoogle Scholar
  • 22a Daluge S. Vince R. J. Org. Chem.  1978,  43:  2311 
    Google Scholar
  • 22b Patil SD. Schneller SW. Hosoya M. Snoeck R. Andrei G. Balzarini J. De Clercq E. J. Med. Chem.  1992,  35:  3372 
    Google Scholar
  • 24 Cesnek M. Hocek M. Holy A. Collect. Czech. Chem. Commun.  2000,  65:  1357 
    CrossrefGoogle Scholar
  • 25a Hocek M. Eur. J. Org. Chem.  2003,  245 
    Google Scholar
  • 25b Havelková M. Dvorak D. Hocek M. Synthesis  2001,  1704 
    Google Scholar
  • 25c Havelková M. Hoces M. Cesnek M. Dovorák D. Synlett  1999,  1145 
    Google Scholar
  • 26 Suzuki A. J. Organomet. Chem.  1999,  576:  147 ; and references cited therein
    Google Scholar
  • 27 Walker SD. Barder TE. Martinelli JR. Buchwald SL. Angew. Chem. Int. Ed.  2004,  43:  1871 
    CrossrefGoogle Scholar
  • 28 De Clercq E. In Vitro and Ex Vivo Test Systems to Rationalize Drug Design and Delivery   Cromelin D. Couvreur P. Duchene D. Editions de Sante; Paris: 1994.  p.108 
    Google Scholar
23

CCDC-636456 contains the supplementary crystallographic data for compound trans-18 reported in this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.